Tag Archives: BIO Investor Forum

BIO Investor Forum Company Snapshot: MAX BioPharma

maxbiopharma

Earlier this week, we featured a presenting company for our upcoming BIO Investor Forum event in San Francisco in our ‘company snapshot‘ feature. For our next post, we spoke to MAX BioPharma, who will be giving a presentation in our Discovery Company presentation track, which features companies in their Seed or Series A financing rounds, with under 25 million raised to date. Read on to learn more about this Discovery Company.   Company Snapshot What Read More >

The One-on-One Compass  |  Leave a comment  |  Email This Post
Tags: , , , , ,

BIO Investor Forum Company Snapshot: AM-Pharma

AM Pharma

The BIO Investor Forum will be taking place this October in San Francisco for its 12th annual event. So far this year, the hot topic is, of course, the hot market. Out of all the therapeutic US companies that have had an IPO in 2013, 71% of them have attended the BIO Investor Forum. The program for the event will thus feature two great panels about the recent IPO activity, in addition to other therapeutic workshops Read More >

The One-on-One Compass  |  Leave a comment  |  Email This Post
Tags: , , , , ,

The Return of the Biotech IPO

Graph

It isn’t just the volume of IPOs this summer that makes this window a victory for hibernating private biotechs and their VC backers, it’s the details of the offerings in terms of price, performance, and type of biotech making the leap onto the public stage. For the last five years we have not seen average offering prices land above expectations, but 2013 is breaking that trend. Price performance is also impressive, with a number of Read More >

Inside BIO Industry Analysis  |  Leave a comment  |  Email This Post
Tags: , , , ,

BIO Investor Forum Veterans Moving Up with the Recent Biotech Deal Surge

150639480

As detailed in The New York Times, the potential for deal-making in the industry has resulted in a big surge in the biotech sector. According to the article, last month alone, seven companies completed I.P.O’s and at least five are lined up behind them. Furthermore, according to data provided by NASDAQ, all 16 of the biotechnology companies that have gone public this year are up 48 percent on average from their offering prices. In fact Read More >

Events  |  Leave a comment  |  Email This Post
Tags:

BIO Convention Post-Con, Plus a Look Ahead

Event Signs

Last month, the biopharma community gathered for the industry’s largest event, the BIO International Convention. We hope the event was successful for everyone who attended. We know it was a busy time for folks, especially based on the numbers from the Partnering System! Here is a quick recap: BIO One-on-One Partnering Stats for BIO2013 A total of 25,537 One-on-One Partnering meetings were scheduled at the event, officially beating last year’s record! Partnering Meeting Requests increased Read More >

The One-on-One Compass  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , ,